Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fish and Richardson
Chubb
Julphar
Baxter
UBS
Queensland Health
Chinese Patent Office
Mallinckrodt

Generated: May 24, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: nilotinib hydrochloride monohydrate

« Back to Dashboard

Nilotinib

CASRN: 641571-10-0UNII:

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Teva
Moodys
Accenture
UBS
Merck
Queensland Health
Argus Health
AstraZeneca